Seth Yakatan
Directeur/Membre du Conseil chez FITLIFE BRANDS, INC.
Postes actifs de Seth Yakatan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FITLIFE BRANDS, INC. | Directeur/Membre du Conseil | 01/09/2015 | - |
| Independent Dir/Board Member | 01/09/2015 | - | |
DCI USA, Inc.
 DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY. | Directeur/Membre du Conseil | 01/02/2005 | - |
Katan Associates International
 Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA. | Fondateur | 01/04/2001 | - |
| Corporate Officer/Principal | 01/04/2001 | - |
Historique de carrière de Seth Yakatan
Anciens postes connus de Seth Yakatan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLARITAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/07/2014 | 03/08/2017 |
| Fondateur | 15/10/2004 | 03/08/2017 | |
| INVION LIMITED | Corporate Officer/Principal | 01/08/2012 | 01/01/2017 |
| ISATORI INC | Comptroller/Controller/Auditor | 03/04/2015 | - |
| Directeur/Membre du Conseil | 12/09/2014 | 30/09/2015 | |
| Directeur Financier/CFO | 03/04/2015 | 30/09/2015 | |
Kalytera Therapeutics, Inc. /Old/
 Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Directeur/Membre du Conseil | 01/01/2014 | - |
| Directeur Général | 01/01/2014 | - | |
| Fondateur | 01/01/2014 | - |
Formation de Seth Yakatan
| University of California, Irvine | Masters Business Admin |
| University of Denver | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Australie | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Founder | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| FITLIFE BRANDS, INC. | Health Technology |
| INVION LIMITED | Health Technology |
| CLARITAS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
DCI USA, Inc.
DCI USA, Inc. Real Estate DevelopmentFinance DCI USA, Inc. owns and operates income-producing real estate, and makes investments in and provides consulting services to other businesses. The company was founded on June 21, 2000 and is headquartered in Brooklyn, NY. | Finance |
Katan Associates International
Katan Associates International Katan Associates International operates as a corporate strategy and finance advisory group which focuses on the global life sciences industry. Its services include consulting, mergers and acquisitions,partnering, and merchant banking. The company was founded by Seth Yakatan and Stanley Yakatan in 2001 and is headquartered in Manhattan Beach, CA. | |
iSatori, Inc.
 iSatori, Inc. Pharmaceuticals: OtherHealth Technology iSatori, Inc. engages in the market, sale, and distribution of nutritional and dietary supplement products. It offers products through online, catalogs and various retail stores. The company was founded by Stephen D. Adelé in 2001 and is headquartered in Omaha, NE. | Health Technology |
Kalytera Therapeutics, Inc. /Old/
Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Kalytera Therapeutics, Inc. develops non-psychoactive cannabinoid and endocannabinoid-like medicines that address the large unmet market needs. Its preclinical studies support the continued investigation of Kalytera drug candidates in a range of conditions, including bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan and David Stefansky in 2014 and is headquartered in Manhattan Beach, CA. | Health Technology |
- Bourse
- Insiders
- Seth Yakatan
- Expérience
